Goldman Sachs Group Inc Novo Nordisk A S Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,983,054 shares of NVO stock, worth $362 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,983,054
Previous 5,692,554
12.46%
Holding current value
$362 Million
Previous $395 Million
12.46%
% of portfolio
0.06%
Previous 0.07%
Shares
22 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.37 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.07 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$900 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$895 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$862 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $164B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...